Más Información
Diputadas celebran a emprendedoras; reconocen a la doctora Araceli Alonso, incluida en las 100 mujeres líderes
Yasmín Esquivel defiende la reforma judicial en Con los de Casa; alejado de la realidad pensar que es una venganza política, afirma
Elección judicial: Aspirantes a cargos comparten carta de motivos y hasta currículum; “Justicia no debe ser inaccesible”, afirman
Niño de 3 años toca “la campana de la victoria” por vencer al cáncer; recibió quimioterapias en el IMSS
Tres de cada 10 estudiantes es víctima de violencia en planteles; exigen reforzar medidas de seguridad
Sanofi Pasteur, Sanofi's vaccines unit, said on Tuesday that its dengue vaccine, Dengvaxia, had received market approval in eleven countries.
To date the vaccine has been approved in Mexico, the Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore, the statement said.
Dengue fever is a mosquito-borne disease caused by four virus serotypes (1 to 4) as categorized by the World Health Organisation. Overall, the disease is seen as a threat to about half of the world's population. Some 400 million people are believed to be infected annually.